Skip to main content
. Author manuscript; available in PMC: 2011 Mar 2.
Published in final edited form as: Mol Cancer Ther. 2010 Mar 2;9(3):523–534. doi: 10.1158/1535-7163.MCT-09-0845

Figure 2. 2-ME2 modulates Bax and Bcl-2 expression profiles in BEAC cells.

Figure 2

Equal amounts of total cell lysates (50μg/lane) were analyzed by immunoblotting with antibodies against Bax or Bcl-2. The blot was subsequently stripped and reprobed with an antibody against β-actin as a control for loading. Quantification of each band was performed by densitometry analysis software. Significant difference between untreated (C) and 2-ME2 treated (T) samples is indicated by *p<0.01, ns, non significant.